Qi-Chun Cai

487 total citations
9 papers, 391 citations indexed

About

Qi-Chun Cai is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Qi-Chun Cai has authored 9 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 4 papers in Immunology and 3 papers in Neurology. Recurrent topics in Qi-Chun Cai's work include Lymphoma Diagnosis and Treatment (6 papers), Immune Cell Function and Interaction (4 papers) and Immune cells in cancer (4 papers). Qi-Chun Cai is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Immune Cell Function and Interaction (4 papers) and Immune cells in cancer (4 papers). Qi-Chun Cai collaborates with scholars based in China. Qi-Chun Cai's co-authors include Xin Huang, Jiabin Lu, Suxia Lin, Jihong Liu, Chunyan Lan, Huiqiang Huang, Ting Wan, Hui-Qiang Huang, Yan Gao and Qing-Qing Cai and has published in prestigious journals such as Cell and Tissue Research, Expert Opinion on Pharmacotherapy and Medical Oncology.

In The Last Decade

Qi-Chun Cai

9 papers receiving 388 citations

Peers

Qi-Chun Cai

IMMUN

ONCOL

PFM

GENET

Huiqiang Huang China

Masaharu Tashima Japan

K. Boye France

Inga Rose United States

Leonhard Muellauer Austria

Mounia S. Braza United States

Liping Su China

Elías Gracia Cuba

Huang Huang Canada

Huiqiang Huang China

Qi-Chun Cai

145 ×0.6

IMMUN

236 ×1.2

ONCOL

185 ×1.4

PFM

60 ×1.2

32 ×0.8

GENET

Citations per year, relative to Qi-Chun Cai Qi-Chun Cai (= 1×) peers Huiqiang Huang

Countries citing papers authored by Qi-Chun Cai

Since Specialization

Citations

This map shows the geographic impact of Qi-Chun Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi-Chun Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi-Chun Cai more than expected).

Fields of papers citing papers by Qi-Chun Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi-Chun Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi-Chun Cai. The network helps show where Qi-Chun Cai may publish in the future.

Co-authorship network of co-authors of Qi-Chun Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Qi-Chun Cai. A scholar is included among the top collaborators of Qi-Chun Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi-Chun Cai. Qi-Chun Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Zhao, Wei, Bin Bai, Qi-Chun Cai, et al.. (2014). Safety and efficacy of non-initial rapid infusion of rituximab plus chemotherapy in Chinese patients with CD20⁺non-Hodgkin’s lymphoma. Expert Opinion on Drug Safety. 14(1). 21–29. 2 indexed citations

Wang, Xiao-Xiao, Hui-Qiang Huang, Bing Bai, et al.. (2014). Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience. Leukemia & lymphoma. 55(11). 2497–2501. 16 indexed citations

Bai, Bing, Hui-Qiang Huang, Qing-Qing Cai, et al.. (2013). Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin’s lymphoma and aggressive non-Hodgkin’s lymphoma. Medical Oncology. 30(1). 350–350. 10 indexed citations

Lan, Chunyan, Xin Huang, Suxia Lin, et al.. (2013). High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer. Cell and Tissue Research. 352(2). 351–359. 55 indexed citations

Huang, Hui-Qiang, et al.. (2013). Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy. Expert Opinion on Pharmacotherapy. 15(2). 163–171. 7 indexed citations

Bai, Bing, Hui-Qiang Huang, Qi-Chun Cai, et al.. (2013). Predictive value of pretreatment positron emission tomography/computed tomography in patients with newly diagnosed extranodal natural killer/T-cell lymphoma. Medical Oncology. 30(1). 339–339. 17 indexed citations

Lan, Chunyan, Xin Huang, Suxia Lin, et al.. (2013). Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer. Technology in Cancer Research & Treatment. 12(3). 259–267. 187 indexed citations

Bai, Bing, Qi-Chun Cai, Qing-Qing Cai, et al.. (2012). High numbers of tumor-associated macrophages correlate with poor prognosis in patients with mature T- and natural killer cell lymphomas. Medical Oncology. 29(5). 3522–3528. 26 indexed citations

Cai, Qi-Chun, Su-Xia Lin, Yi Xia, et al.. (2011). High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma. Medical Oncology. 29(4). 2317–2322. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact